Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00134420 · ClinicalTrials.gov registry record · Phase 3
Growth Hormone and Chromosome 18q- and Abnormal Growth
A Phase 3 study of Growth Hormone Deficiency and Loss of Chromosome 18q, sponsored by The University of Texas Health Science Center at San Antonio.
- Completed
- Registry status
- Phase 3
- Development phase
- 20
- Enrollment target
- 1
- Study location
NCT00134420: Completed Phase 3 study of Growth Hormone Deficiency and Loss of Chromosome 18q, sponsored by The University of Texas Health Science Center at San Antonio.
NCT00134420 is a Phase 3 study of Growth Hormone Deficiency and Loss of Chromosome 18q that has completed, run by The University of Texas Health Science Center at San Antonio. The registered enrollment target is 20 participants, below the 386-participant average among 16 other Growth Hormone Deficiency trials with a reported enrollment target (95% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00134420, a Phase 3 study of Growth Hormone Deficiency and Loss of Chromosome 18q, has completed, sponsored by The University of Texas Health Science Center at San Antonio.
- COMPLETED
- Registry status
- Phase 3
- Development phase
- 20 participants
- Enrollment target
- 1
- Study location
Study Summary
We, the investigators at the University of Texas Health Science Center at San Antonio, want to learn if height and IQ (intelligence quotient) scores are improved by growth hormone (GH) treatment in children with chromosome 18 deletions and abnormal growth. Data from a previous study showed that growth hormone improved height in all children with 18q- and growth hormone deficiency. In addition, most of the study participants on growth hormone treatment showed an increase in IQ scores.
Conditions Studied
Interventions
- DRUG Nutropin AQ
- PROCEDURE Arginine and Clonidine Stimulation Testing
- PROCEDURE Growth Factors Laboratory Testing
- PROCEDURE Neuropsychological Testing
Study Locations (1)
Texas
- The University of Texas Health Science Center at San Antonio - San Antonio
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 20 participants |
| Start Date | 2001-02 |
| Est. Completion | 2005-06 |
| Phase | Phase 3 |
What the finished NCT00134420 record still lists
NCT00134420 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 20 participants, a relatively small participant target, below the 386-participant average among 16 other Growth Hormone Deficiency trials with a reported enrollment target (95% lower).
The record links to 2 conditions, with Growth Hormone Deficiency appearing as the primary indexed condition, and to 4 interventions - of which Nutropin AQ is the first listed.
NCT00134420 reports a single indexed study location in Texas.
Frequently Asked Questions
What is clinical trial NCT00134420 about?
NCT00134420 is a clinical study titled "Growth Hormone and Chromosome 18q- and Abnormal Growth". We, the investigators at the University of Texas Health Science Center at San Antonio, want to learn if height and IQ (intelligence quotient) scores are improved by growth hormone (GH) treatment in children with chromosome 18 deletions and abnormal growth. Data from a previous study showed that grow...
What is the current status of trial NCT00134420?
This trial is currently completed. It is a Phase 3 study. The enrollment target is 20 participants. The study started on 2001-02. Estimated completion is 2005-06.
What conditions does trial NCT00134420 study?
This clinical trial studies the following conditions: Growth Hormone Deficiency, Loss of Chromosome 18q.
What interventions are being tested in trial NCT00134420?
The interventions under investigation include: Nutropin AQ (DRUG), Arginine and Clonidine Stimulation Testing (PROCEDURE), Growth Factors Laboratory Testing (PROCEDURE), Neuropsychological Testing (PROCEDURE).
Who is sponsoring clinical trial NCT00134420?
This trial is sponsored by The University of Texas Health Science Center at San Antonio, which has 378 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00134420 being conducted?
This trial has 1 study location across Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Growth Hormone Deficiency
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT00134420's enrollment target sits among peer trials
20 13th of 16 higher than 3 of 16 other Growth Hormone Deficiency trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Growth Hormone Deficiency trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Genotropin Study Assessing Use of Injection Pen
COMPLETED · Phase 3
-
A Trial to Compare the Efficacy and Safety of Once-weekly Lonapegsomatropin With Placebo and a Daily Somatropin Product in Adults With Growth Hormone Deficiency
COMPLETED · Phase 3
-
A US Non-interventional, Effectiveness and Safety Study of Patients Treated With SKYTROFA
RECRUITING
-
A Post-Authorisation Safety Study (PASS) of Patients Treated With Lonapegsomatropin
RECRUITING
-
Effects of GH and Lirglutide on AgRP
RECRUITING · Phase 4
-
Chromosome 18 Clinical Research Center
RECRUITING
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00573339 · 20 participants
Cardiac Magnetic Resonance Imaging (MRI) Normal Reference Control Group Testing
- NCT00692939 · 20 participants · Phase 1
Autologous Stem Cell Transplantation for Crohn's Disease
- NCT00967785 · 20 participants · Phase 1
A Phase I Study of Mozobil in the Treatment of Patients With WHIMS
- NCT01406691 · 20 participants · Phase 4
Light Flashes to Treat Delayed Sleep Phase Disorder (DSPD)
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia